Clinical Trials Browser

Phase EARLY_PHASE1 × Prostatic Neoplasms × darolutamide × Clear all

NCT05683964 2026-02-13

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms